Pancreatic Cancer Research

ResearcherGeorgetown UniversityActive in the last 2 years

Ivana Peran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7399-7452; OpenAlex author ID A5108463442. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper, 1 grant · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-25-1481↗
  2. Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment. Co-author DOI 10.3389/fonc.2023.1286861↗
  3. A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer. Co-author DOI 10.1016/j.ecoenv.2022.113330↗
  4. Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors. Co-author DOI 10.3390/cancers14061517↗
  5. Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection. First author DOI 10.3390/app9224784↗
  6. Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mecha… Co-author DOI 10.1158/1078-0432.ccr-18-0290↗
  7. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/1471-2164-16-s1-s1↗
  8. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. Co-author DOI 10.1371/journal.pone.0020687↗

Grants 1

  1. Career Development Award: Ivana Peran (stromal cadherin 11 and chemotherapy response) AWARD pancan:2023-ivana-peran-phd-career-development-award-ivana-peran-str

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anton Wellstein · 4 shared papers, 2011–2022 · strength 0.38
  2. Eveline E. Vietsch · 2 shared papers, 2019–2022 · strength 0.30
  3. Zoe X. Malchiodi · 1 shared paper, 2026 · strength 0.24
  4. Elana Judith Fertig · 1 shared paper, 2026 · strength 0.24
  5. Alexander A. Lekan · 1 shared paper, 2026 · strength 0.24
  6. Won Jin Ho · 1 shared paper, 2026 · strength 0.24
  7. Louis M. Weiner · 1 shared paper, 2026 · strength 0.24
  8. Aimy Sebastian · 1 shared paper, 2023 · strength 0.17
  9. Gabriela G. Loots · 1 shared paper, 2023 · strength 0.17
  10. Naiem Tony Issa · 1 shared paper, 2022 · strength 0.14
  11. Sivanesan Dakshanamurthy · 1 shared paper, 2022 · strength 0.14
  12. Matthew McCoy · 1 shared paper, 2018 · strength 0.12
  13. Fleur van der Sijde · 1 shared paper, 2019 · strength 0.10
  14. Mustafa Suker · 1 shared paper, 2019 · strength 0.10
  15. Casper H.J. van Eijck · 1 shared paper, 2019 · strength 0.10
  16. Joseph J. LaConti · 2 shared papers, 2011–2015 · strength 0.08
  17. Jerry W. Shay · 1 shared paper, 2015 · strength 0.05
  18. Sung Eun Kim · 1 shared paper, 2011 · strength 0.03
  19. John Lindsay Marshall · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.